Marketing In Brief
This article was originally published in The Rose Sheet
Executive Summary
B&BW derm line: Bath & Body Works partners with New York dermatologist Patricia Wexler, MD, Beth Israel Medical Center, to create a skin care line slated to debut in select Bath & Body Works, CO Bigelow and Henri Bendel stores in September, Limited Brands division announces May 6. While details have not yet been finalized, Bath & Body Works notes the concept is "a long time in the making" and that Wexler is "fully in charge of the line from formulation to packaging." The range will represent the first skin care line for Wexler, who has consulted on the creation of other skin care launches for Donna Karan and Revlon (1"The Rose Sheet" July 3, 2000, In Brief). Deal furthers Bath & Body Works' goal of becoming a "world-class beauty destination," firm notes...
You may also be interested in...
Patricia Wexler Skin Care Treats Inflammation With MMP Inhibitors
Patricia Wexler M.D. Dermatology skin care is formulated with proprietary MMPi technology to inhibit matrix metalloproteinases, reducing inflammation and rejuvenating skin at the structural level, according to Bath & Body Works
Patricia Wexler Skin Care Treats Inflammation With MMP Inhibitors
Patricia Wexler M.D. Dermatology skin care is formulated with proprietary MMPi technology to inhibit matrix metalloproteinases, reducing inflammation and rejuvenating skin at the structural level, according to Bath & Body Works
Revlon
Dermatologist Pamela Wexler, MD, Beth Israel Medical Center, signs agreement to consult on the "development and promotion" of new skin care and cosmetics products slated to bow in late 2000 and early 2001, the company announces June 28. Wexler is a member of the American Board of Dermatology and American Board of Internal Medicine. The products will contain Senetek's patented Kinetin technology; Revlon signed a $3 mil. licensing agreement with Senetek in June (1"The Rose Sheet" June 19, In Brief)